Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Conferences, Workshops, Symposiums, and Seminars
  4. Cas9/gRNAs Selective Targeting of the Beethoven Tmc-1 Mutant Allele for Treating Progressive Hearing Loss by AAV-Based Delivery
 
conference paper

Cas9/gRNAs Selective Targeting of the Beethoven Tmc-1 Mutant Allele for Treating Progressive Hearing Loss by AAV-Based Delivery

Solanes, Paola  
•
Pan, Bifeng
•
Aebischer, Patrick  
Show more
May 1, 2018
Molecular Therapy
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
  • Details
  • Metrics
Type
conference paper
Web of Science ID

WOS:000435342201165

Author(s)
Solanes, Paola  
Pan, Bifeng
Aebischer, Patrick  
Holt, Jeffrey R.
Schneider, Bernard  
Date Issued

2018-05-01

Publisher

CELL PRESS

Publisher place

Cambridge

Published in
Molecular Therapy
Volume

26

Issue

5

Start page

138

End page

139

Subjects

Biotechnology & Applied Microbiology

•

Genetics & Heredity

•

Medicine, Research & Experimental

•

Biotechnology & Applied Microbiology

•

Genetics & Heredity

•

Research & Experimental Medicine

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LEN  
PTBTG  
Event nameEvent placeEvent date
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Chicago, IL

May 16-19, 2018

Available on Infoscience
December 13, 2018
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/152341
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés